Reports for SANDOZ CANADA INCORPORATED
Company Name
SANDOZ CANADA INCORPORATED
Totals |
||
Shortage reports |
2123 |
|
| Actual shortage: | 50 (2%) | |
| Anticipated shortage: | 9 (0%) | |
| Avoided shortage: | 19 (1%) | |
| Resolved: | 2045 (96%) | |
Discontinuation Reports |
101 |
|
| To be discontinued: | 1 (1%) | |
| Discontinued: | 98 (97%) | |
| Reversed: | 2 (2%) | |
Late reports |
444 (20%) |
|
Overdue reports |
38 (63%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| NALOXONE HCL INJECTION - 1MG/ML USP | 1mg/mL | INJ | Resolved | 2017-03-14 | 2017-06-26 | 2609 |
| NALOXONE HCL INJECTION - 1MG/ML USP | 1MG | LIQUID | Resolved | 2023-01-19 | 2023-03-21 | 181704 |
| NALOXONE HCL INJECTION - 1MG/ML USP | 1MG | LIQUID | Resolved | 2019-04-05 | 2019-06-28 | 80573 |
| NALOXONE HCL INJECTION - 1MG/ML USP | 1MG | LIQUID | Resolved | 2020-12-07 | 2021-02-16 | 129727 |
| NALOXONE HCL INJECTION - 1MG/ML USP | 1MG | LIQUID | Resolved | 2022-10-19 | 2022-12-29 | 172174 |
| NOREPINEPHRINE BITARTRATE INJECTION USP | 1MG | LIQUID | Resolved | 2022-04-20 | 2022-10-13 | 159100 |
| NOREPINEPHRINE BITARTRATE INJECTION USP | 1MG | LIQUID | Resolved | 2018-01-08 | 2018-01-18 | 35329 |
| OLANZAPINE FOR INJECTION | 10MG | POWDER FOR SOLUTION | Resolved | 2017-05-30 | 2017-10-18 | 11488 |
| OLANZAPINE FOR INJECTION | 10MG | POWDER FOR SOLUTION | Resolved | 2018-01-18 | 2018-02-05 | 36548 |
| OLANZAPINE FOR INJECTION | 10MG | POWDER FOR SOLUTION | Resolved | 2020-06-08 | 2023-11-17 | 116949 |
| OMEP | 20MG | CAPSULE (DELAYED RELEASE) | Resolved | 2019-12-10 | 2023-11-17 | 100818 |
| OMEP | 20MG | CAPSULE (DELAYED RELEASE) | Resolved | 2018-02-12 | 2018-03-24 | 39575 |
| OMEP | 20MG | CAPSULE (DELAYED RELEASE) | Resolved | 2017-03-14 | 2017-05-17 | 2668 |
| OMEP | 20MG | CAPSULE (DELAYED RELEASE) | Resolved | 2017-09-07 | 2017-10-25 | 21295 |
| ONDANSETRON HYDROCHLORIDE DIHYDRATE INJECTION | 2MG | SOLUTION | Resolved | 2017-08-07 | 2017-10-19 | 18328 |
| ONDANSETRON HYDROCHLORIDE DIHYDRATE INJECTION | 2MG | SOLUTION | Resolved | 2019-03-05 | 2019-04-17 | 77732 |
| ONDANSETRON INJECTION USP -(PRESERVATIVE FREE) | 2MG | SOLUTION | Resolved | 2023-08-21 | 2024-01-03 | 202547 |
| ONDANSETRON INJECTION USP -(WITH PRESERVATIVE) | 2MG | SOLUTION | Resolved | 2024-12-10 | 2025-04-22 | 245205 |
| ONDANSETRON INJECTION USP -(WITH PRESERVATIVE) | 2MG | SOLUTION | Resolved | 2017-07-18 | 2017-10-19 | 16268 |
| ONDANSETRON INJECTION USP -(WITH PRESERVATIVE) | 2MG | SOLUTION | Resolved | 2017-08-07 | 2017-10-19 | 18325 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ZOFRAN ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2023-03-14 | 2023-03-14 | 187062 |